Retrospective survey of bone fracture in patients with Arimidex 1mg

Study identifier:NIS-OJP-ARI-2007/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Retrospective survey of bone fracture in post-menopausal breast cancer patients with Arimidex 1 mg as adjuvant therapy

Medical condition

Breast Cancer

Phase

Healthy volunteers

Study drug

Sex

Female

Actual Enrollment

2205

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Jan 2008

Primary Completion Date: -

Study Completion Date: 01 Dec 2008

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions

Documents available

CSR-NIS-OJP-ARI-2007/1
Download
CSR-NIS-OJP-ARI-2007-1.pdf
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Clinical Study Information

Hiroyo.Kuwabara@astrazeneca.com

Investigators

Principal Investigator

AstraZeneca Japan Medical Director MD

AstraZeneca